You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 154 No. 14, 25 July 1994 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigations
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Detection of Borreliacidal Antibodies by Flow Cytometry

An Accurate, Highly Specific Serodiagnostic Test for Lyme Disease

Steven M. Callister, PhD; Ronald F. Schell, PhD; Lony C. L. Lim; Dean A. Jobe, MS; Kay L. Case, MT(ASCP); Gary L. Bryant, MD; Paul E. Molling

Arch Intern Med. 1994;154(14):1625-1632.


Abstract



Background
Borreliacidal antibodies can be detected in serum samples from patients with early or late Lyme disease symptoms. When these serum samples are incubated with Borrelia burgdorferi and complement, spirochetes are rapidly killed. Detection of these antibodies can be used as a serodiagnostic test.

Methods
Individual serum samples containing IgM or IgG borreliacidal antibodies were used to develop a method for detection using flow cytomety. An additional 10 case-defined Lyme disease serum samples and 10 normal serum samples were used to confirm appropriate flow cytometric parameters. To determine specificity, 157 normal serum samples and 104 potential cross-reactive serum samples were tested for borreliacidal activity and antibodies to B burgdorferi using indirect fluorescent antibody or enzyme immunoassay.

Results
Flow cytometry can be used to detect borreliacidal activity within 16 to 24 hours after incubation of B burgdorferi organisms, Lyme disease serum, and complement. Significant borreliacidal activity was detected in all Lyme disease serum samples. The percentages of positive normal serum samples were comparable (6% to 10%) using all three assays. In addition, the indirect fluorescent antibody and enzyme immunoassay identified 41 (39%) and 47 (45%) potential cross-reactive serum samples as positive, respectively. In contrast, significant borreliacidal activity was not detected in any potential cross-reactive serum samples.

Conclusion
Detection of borreliacidal antibody, unlike indirect fluorescent antibody and enzyme immunoassay, is an accurate, highly specific serodiagnostic test for detection of Lyme disease.

(Arch Intern Med. 1994;154:1625-1632)



Author Affiliations



From the Microbiology Research Laboratory, Gundersen Medical Foundation (Drs Callister and Bryant, Messrs Jobe and Moiling, and Ms Case) and Department of Rheumatology, Gundersen Clinic (Dr Bryant), La Crosse, Wis, and Departments of Bacteriology (Dr Schell and Mr Lim), Medical Microbiology and Immunology (Dr Schell), and Wisconsin State Laboratory of Hygiene (Dr Schell), University of Wisconsin, Madison.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Significantly Improved Accuracy of Diagnosis of Early Lyme Disease by Peptide Enzyme-Linked Immunosorbent Assay Based on the Borreliacidal Antibody Epitope of Borrelia burgdorferi OspC
Jobe et al.
CVI 2008;15:981-985.
ABSTRACT | FULL TEXT  

Borreliacidal OspC Antibody Response of Canines with Lyme Disease Differs Significantly from That of Humans with Lyme Disease
Lovrich et al.
CVI 2007;14:635-637.
ABSTRACT | FULL TEXT  

Diagnosis of Lyme Borreliosis
Aguero-Rosenfeld et al.
Clin. Microbiol. Rev. 2005;18:484-509.
ABSTRACT | FULL TEXT  

Borreliacidal OspC Antibodies Specific for a Highly Conserved Epitope Are Immunodominant in Human Lyme Disease and Do Not Occur in Mice or Hamsters
Lovrich et al.
CVI 2005;12:746-751.
ABSTRACT | FULL TEXT  

C-Terminal Region of Outer Surface Protein C Binds Borreliacidal Antibodies in Sera from Patients with Lyme Disease
Jobe et al.
CVI 2003;10:573-578.
ABSTRACT | FULL TEXT  

Ability of the Borreliacidal Antibody Test To Confirm Lyme Disease in Clinical Practice
Callister et al.
CVI 2002;9:908-912.
ABSTRACT | FULL TEXT  

In Vitro Assessment of Antiborrelial Activity of OspA Vaccine Sera
Fawcett et al.
CVI 2002;9:919-920.
ABSTRACT | FULL TEXT  

Detection of Borreliacidal Antibodies in Dogs after Challenge with Borrelia burgdorferi-Infected Ixodes scapularis Ticks
Callister et al.
J. Clin. Microbiol. 2000;38:3670-3674.
ABSTRACT | FULL TEXT  

Protection Elicited by Native Outer Membrane Protein Oms66 (p66) against Host-Adapted Borrelia burgdorferi: Conformational Nature of Bactericidal Epitopes
Exner et al.
Infect. Immun. 2000;68:2647-2654.
ABSTRACT | FULL TEXT  

Detection of Borreliacidal Antibodies in Lyme Borreliosis Patient Sera Containing Antimicrobial Agents
Jobe et al.
CVI 1999;6:930-933.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.